Organon Balance Sheet Health
Financial Health criteria checks 0/6
Organon has a total shareholder equity of $-70.0M and total debt of $8.8B, which brings its debt-to-equity ratio to -12514.3%. Its total assets and total liabilities are $12.1B and $12.1B respectively. Organon's EBIT is $1.3B making its interest coverage ratio 2.5. It has cash and short-term investments of $693.0M.
Key information
-12,514.3%
Debt to equity ratio
US$8.76b
Debt
Interest coverage ratio | 2.5x |
Cash | US$693.00m |
Equity | -US$70.00m |
Total liabilities | US$12.13b |
Total assets | US$12.06b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: OGN * has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: OGN * has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: OGN * has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: OGN *'s has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Debt Coverage: OGN *'s debt is not well covered by operating cash flow (9.1%).
Interest Coverage: OGN *'s interest payments on its debt are not well covered by EBIT (2.5x coverage).